Single User PDF
GBP 1499.00  

1-5 User License
GBP 2999.00  

PDF Site License
GBP 4999.00  

PDF Corporate License
GBP 6999.00  

UK Head Office
+44(0)1494 771930
USA
+(1) 508 861 0401
or Buy Now! online

Hot Reports:
Global Biosimilars: A return to optimism?


Cardiac Rhythm Management Devices: World Market Outlook 2011-2021


Chinese Pharmaceutical Market 2012-2022


Biobanking for Medicine: Technology and Market 2012-2022


Point of Care Diagnostics: World Market Outlook 2012-2021


Generic Drugs: Global collaboration opportunities


Covidien Medical Device Company Intelligence Report


The Outlook for Pharmaceuticals in North East Asia

Table of Contents

Market Study
Published: December 2009
Pages: 151
Tables: For full details, please email keithw@cmsinfo.com
From: GBP 1499.00  Buy Now!
Research from: Visiongain
Sector: Biotechnology

The global pharmaceutical biotech market continues to experience high growth, with developers ranging from major pharmaceutical companies to specialist pharmaceutical firms. Significant R&D efforts and innovative new treatments will lead to further expansion of the pharma biotech market. This new report – Global Pharmaceutical Biotech Market 2010-2025 – explains why that market will expand, revealing where the most exciting developments will lie.

This report examines markets for the following therapy classes:

• Oncology
• Insulins
• Immunosuppressive agents
• Autoimmune agents
• Erythropoietin products
• Immunostimulating agents
• Interferons
• Pure vaccines
• Blood coagulation factors
• Growth hormones.

Which therapy classes will lead the pharma biotech market in future? Where will the best commercial opportunities lie from 2010 onwards? What are the most-crucial drivers and restraints in this increasingly-important market? This report will provide you with the information that you need to understand current trends and future directions in the global biopharma sector, seeing how it will further bolster the global pharma industry and market. In particular, we discuss prospects for the following products:

• Enbrel
• Remicade
• Avastin
• Humira
• MabThera
• Herceptin
• Lantus
• Neulasta
• Glivec
• Epogen. 

Comprehensive analysis of the global biopharma market:

Global Pharmaceutical Biotech Market 2010-2025 critically examines that sector through a comprehensive review of information sources and original analysis. The report provides detailed sales forecasts, market share analyses, discussions of pipeline developments and analyses of commercial drivers and restraints, including a SWOT analysis. There are over 100 tables and figures included. The result is a comprehensive market- and industry-centred study, with detailed analyses to benefit your work.

Why you should buy Global Pharmaceutical Biotech Market 2010-2025?

In this report you will receive the following benefits in particular:

• You will assess the current market for pharma biotech products
• You will review the overall pharma biotech market, including a global sales forecast for 2010 to 2025
• You will receive sales forecasts for the ten leading biotech therapy classes from 2010 to 2025, with detailed discussions
• You will receive sales forecasts for the leading products in this market from 2010 to 2025, with detailed discussions of market potential and competition
• You will receive sales forecasts for leading geographical markets from 2010 to 2025, with informed discussion
• You will examine commercial drivers and restraints in depth, exploring their significance
• You will discover the most-exciting pipeline developments in the sector, across a range of therapy classes.
• Market growth, novel technologies and expansion into new therapeutic areas - our latest report examines the significant technological and commercial opportunities in the global biopharma market.

Nobody with an interest in the pharmaceutical biotech market should overlook this new study. We predict that total revenues will increase throughout our forecast period, 2010 to 2025. With new and increasingly innovative products and a strong pipeline, this crucial pharma sector holds high potential. Do you want to harness those opportunities?

Companies Listed

Top of Page